184 related articles for article (PubMed ID: 27684077)
1. The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis.
Xu Z; Xu W; Cheng H; Shen W; Ying J; Cheng F; Xu W
PLoS One; 2016; 11(9):e0163719. PubMed ID: 27684077
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
[TBL] [Abstract][Full Text] [Related]
3. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis.
Xin-Ji Z; Yong-Gang L; Xiao-Jun S; Xiao-Wu C; Dong Z; Da-Jian Z
Int J Surg; 2015 Sep; 21():84-91. PubMed ID: 26225826
[TBL] [Abstract][Full Text] [Related]
5. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
[TBL] [Abstract][Full Text] [Related]
6. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of platelet-to-lymphocyte ratio on overall survival in gastric cancer: a systematic review and meta-analysis.
Cao W; Yao X; Cen D; Zhi Y; Zhu N; Xu L
BMC Gastroenterol; 2020 Jan; 20(1):16. PubMed ID: 31959103
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis.
Wang X; Ni X; Tang G
Front Oncol; 2019; 9():757. PubMed ID: 31475109
[No Abstract] [Full Text] [Related]
9. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
[TBL] [Abstract][Full Text] [Related]
10. [Research progress of peripheral blood count test in the evaluation of prognosis of gastric cancer].
Xu Z; Cheng H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):236-240. PubMed ID: 28226360
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
[TBL] [Abstract][Full Text] [Related]
13. Elevated Platelet to Lymphocyte Ratio Is Associated with Poor Survival Outcomes in Patients with Colorectal Cancer.
Gu X; Gao XS; Qin S; Li X; Qi X; Ma M; Yu H; Sun S; Zhou D; Wang W; Xiong W
PLoS One; 2016; 11(9):e0163523. PubMed ID: 27658306
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
15. Utility of Pretreatment Blood Platelet-To-Lymphocyte Ratio in Prediction of Clinical Outcomes and Chemosensitivity in Patients with Advanced Gastric Cancer: A Meta-Analysis.
Peng X; Zeng W; Tang B; He A; Zhang M; Luo R
Med Sci Monit; 2022 Jan; 28():e933449. PubMed ID: 35095093
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
Li W; Tao L; Lu M; Xiu D
Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Platelet-to-Lymphocyte Ratio in Urological Cancers: A Meta-Analysis.
Li DY; Hao XY; Ma TM; Dai HX; Song YS
Sci Rep; 2017 Nov; 7(1):15387. PubMed ID: 29133845
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Xu H; He A; Liu A; Tong W; Cao D
Int Immunopharmacol; 2019 Dec; 77():105957. PubMed ID: 31677498
[TBL] [Abstract][Full Text] [Related]
19. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer.
Koh CH; Bhoo-Pathy N; Ng KL; Jabir RS; Tan GH; See MH; Jamaris S; Taib NA
Br J Cancer; 2015 Jun; 113(1):150-8. PubMed ID: 26022929
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer.
Gu X; Gao XS; Cui M; Xie M; Peng C; Bai Y; Guo W; Han L; Gu X; Xiong W
Oncotarget; 2016 Aug; 7(31):49878-49887. PubMed ID: 27409665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
